Abemaciclib is an oral medication used in the treatment of certain types of cancer. It is a cyclin-dependent kinase inhibitor (CDK4/6 inhibitor), designed to interfere with the growth and division of cancer cells. Specifically, it targets the proteins CDK4 and CDK6, which are crucial for cell cycle progression.
